Apogee Therapeutics Inc (NAS:APGE)
$ 134.17 -0.14 (-0.1%) Market Cap: 10.15 Bil Enterprise Value: 9.10 Bil PE Ratio: 0 PB Ratio: 8.00 GF Score: 12/100

Apogee Therapeutics Inc at Citi Global Healthcare Conference Transcript

Dec 03, 2025 / 02:45PM GMT
Release Date Price: $74.55 (+7.84%)
Geoffrey Meacham
Citigroup - Analyst

The second day of the Citi Global Healthcare Conference. So I'm Geoff Meacham. I'm the senior biopharma analyst. My team here too, Nishant, Ross, Mary Kate.

So we're thrilled to have Apogee with us. So we have Jane Henderson, CFO. We have Jeff Hartness, CCO. So guys, thanks for joining us. Good to see you.

Jane Henderson
Apogee Therapeutics Inc - Chief Financial Officer

Thank you, Geoff.

Jeff Hartness
Apogee Therapeutics Inc - Chief Commercial Officer

Good to see you as well.

Geoffrey Meacham
Citigroup - Analyst

So we have some questions, but do you want to like kind of give maybe a quick summary? Or do you want to get ready into questions? It's totally up to you.

Jane Henderson
Apogee Therapeutics Inc - Chief Financial Officer

I can give a very quick summary. First of all, thank you for having us. We're really pleased to be here and look forward to a robust discussion. 2026

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot